Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Biochem Biophys Rep ; 11: 161-173, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28955781

ABSTRACT

The mesencephalic astrocyte-derived neurotrophic factor (MANF) belongs to a recently discovered family of neurotrophic factors. MANF can be secreted but is generally resident within the endoplasmic reticulum (ER) in neuronal and non-neuronal cells, where it is involved in the ER stress response with pro-survival effects. Here we report the discovery of the MANF homolog SDMANF in the sponge Suberites domuncula. The basal positioning of sponges (phylum Porifera) in the animal tree of life offers a unique vantage point on the early evolution of the metazoan-specific genetic toolkit and molecular pathways. Since sponges lack a conventional nervous system, SDMANF presents an enticing opportunity to investigate the evolutionary ancient role of these neurotrophic factors. SDMANF shares considerable sequence similarity with its metazoan homologs. It also comprises a putative protein binding domain with sequence similarities to the Bcl-2 family of apoptotic regulators. In Suberites, SDMANF is expressed in the vicinity of bacteriocytes, where it co-localizes with the toll-like receptor SDTLR. In transfected human cells, SDMANF was detected in both the organelle protein fraction and the cell culture medium. The intracellular SDMANF protein level was up-regulated in response to both a Golgi/ER transport inhibitor and bacterial lipopolysaccharides (LPS). Upon LPS challenge, transfected cells revealed a decreased caspase-3 activity and increased cell viability with no inducible Bax expression compared to the wild type. These results suggest a deep evolutionary original cytoprotective role of MANF, at the crossroads of innate immune and apoptotic pathways, of which a neurotrophic function might have arisen later in metazoan evolution.

2.
Front Cell Neurosci ; 9: 142, 2015.
Article in English | MEDLINE | ID: mdl-25954155

ABSTRACT

We have deployed recombinant adeno-associated viruses equipped with tetracycline-controlled genetic switches to manipulate gene expression in mouse brain. Here, we show a combinatorial genetic approach for inducible, cell type-specific gene expression and Cre/loxP mediated gene recombination in different brain regions. Our chemical-genetic approach will help to investigate 'when', 'where', and 'how' gene(s) control neuronal circuit dynamics, and organize, for example, sensory signal processing, learning and memory, and behavior.

3.
Crit Rev Toxicol ; 41(3): 175-86, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21401325

ABSTRACT

The European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), the International Life Sciences Institute (ILSI) Research Foundation (RF), and the ILSI Health and Environmental Sciences Institute (HESI) hosted a workshop in November 2009 to review current practice in the application of mode of action (MOA) considerations in chemical risk assessment. The aim was to provide a rationale for a more general, but flexible approach and to propose steps to facilitate broader uptake and use of the MOA concept. There was consensus amongst the workshop participants that it will require substantial effort and cooperation from the multiple disciplines involved to embrace a common, consistent, and transparent approach. Setting up a repository of accepted MOAs and associated guidance concerning appropriate data to support specific MOAs for critical effects would facilitate categorization of chemicals and allow predictions of toxicity outcomes by read-across. This should in future contribute to the reduction of toxicity testing in animals. The workshop participants also acknowledged the value and importance of human data and the importance of integrating information from biological pathway analyses into current MOA/human relevance frameworks.


Subject(s)
Consensus Development Conferences as Topic , Decision Support Techniques , Environmental Pollution/legislation & jurisprudence , Government Regulation , Hazardous Substances/toxicity , Academies and Institutes , Animals , Ecotoxicology/legislation & jurisprudence , Foundations , Humans , Risk Assessment/methods
4.
Mol Cell Neurosci ; 44(3): 201-9, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20206270

ABSTRACT

The scaffolding protein gephyrin is essential for the clustering of glycine and GABA(A) receptors (GABA(A)Rs) at inhibitory synapses. Here, we provide evidence that the size of the postsynaptic gephyrin scaffold is controlled by dephosphorylation reactions. Treatment of cultured hippocampal neurons with the protein phosphatase inhibitors calyculin A and okadaic acid reduced the size of postsynaptic gephyrin clusters and increased cytoplasmic gephyrin staining. Protein phosphatase 1 (PP1) was found to colocalize with gephyrin at selected postsynaptic sites and to interact with gephyrin in transfected cells and brain extracts. Alanine or glutamate substitution of the two established serine/threonine phosphorylation sites in gephyrin failed to affect its clustering at inhibitory synapses and its ability to recruit gamma2 subunit containing GABA(A)Rs. Our data are consistent with the postsynaptic gephyrin scaffold acting as a platform for PP1, which regulates gephyrin cluster size by dephosphorylation of gephyrin- or cytoskeleton-associated proteins.


Subject(s)
Carrier Proteins/metabolism , Membrane Proteins/metabolism , Protein Phosphatase 1/metabolism , Synapses/metabolism , Animals , Carrier Proteins/genetics , Cells, Cultured , Cytoskeleton/metabolism , Cytoskeleton/ultrastructure , Enzyme Inhibitors/pharmacology , Hippocampus/cytology , Humans , Marine Toxins , Membrane Proteins/genetics , Neurons/drug effects , Neurons/metabolism , Neurons/ultrastructure , Okadaic Acid/pharmacology , Oxazoles/pharmacology , Protein Phosphatase 1/antagonists & inhibitors , Rats , Receptors, GABA/metabolism , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Synapses/drug effects
5.
Biomaterials ; 30(8): 1648-56, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19118892

ABSTRACT

Biosilicification in sponges is initiated by formation of proteinaceous filaments, predominantly consisting of silicateins. Silicateins enzymatically catalyze condensation of silica nanospheres, resulting in symmetric skeletal elements (spicules). In order to create tailored biosilica structures in biomimetic approaches it is mandatory to elucidate proteins that are fundamental for the assembly of filaments. Silintaphin-1 is a core component of modularized filaments and also part of a spicule-enfolding layer. It bears no resemblance to other proteins, except for the presence of an interaction domain that is fundamental for its function as scaffold/template. In the presence of silicatein silintaphin-1 facilitates the formation of in vitro filaments. Also, it directs the assembly of gamma-Fe(2)O(3) nanoparticles and surface-immobilized silicatein to rod-like biocomposites, synthetic spicules. Thus, silintaphin-1 will contribute to biomimetic approaches that pursue a controlled formation of patterned biosilica-based materials. Its combination with gamma-Fe(2)O(3) nanoparticles and immobilized silicatein will furthermore inspire future biomedical applications and clinical diagnostics.


Subject(s)
Biomimetic Materials/metabolism , Calcification, Physiologic , Cathepsins/metabolism , Proteins/metabolism , Suberites/enzymology , Amino Acid Sequence , Animals , Antibodies/pharmacology , Calcification, Physiologic/drug effects , Cathepsins/ultrastructure , DNA, Complementary/genetics , Enzymes, Immobilized/metabolism , Ferric Compounds/metabolism , Molecular Sequence Data , Protein Binding/drug effects , Protein Transport/drug effects , Proteins/chemistry , Recombinant Proteins/metabolism , Regeneration/drug effects , Silicic Acid/pharmacology , Suberites/anatomy & histology , Suberites/cytology , Suberites/drug effects , Two-Hybrid System Techniques
6.
Nat Methods ; 5(9): 797-804, 2008 Sep.
Article in English | MEDLINE | ID: mdl-19160514

ABSTRACT

Measurement of population activity with single-action-potential, single-neuron resolution is pivotal for understanding information representation and processing in the brain and how the brain's responses are altered by experience. Genetically encoded indicators of neuronal activity allow long-term, cell type-specific expression. Fluorescent Ca2+ indicator proteins (FCIPs), a main class of reporters of neural activity, initially suffered, in particular, from an inability to report single action potentials in vivo. Although suboptimal Ca2+-binding dynamics and Ca2+-induced fluorescence changes in FCIPs are important factors, low levels of expression also seem to play a role. Here we report that delivering D3cpv, an improved fluorescent resonance energy transfer-based FCIP, using a recombinant adeno-associated virus results in expression sufficient to detect the Ca2+ transients that accompany single action potentials. In upper-layer cortical neurons, we were able to detect transients associated with single action potentials firing at rates of <1 Hz, with high reliability, from in vivo recordings in living mice.


Subject(s)
Brain/physiology , Calcium/analysis , Calmodulin/genetics , Fluorescence Resonance Energy Transfer , Recombinant Fusion Proteins/genetics , Action Potentials , Animals , Cells, Cultured , Dependovirus/genetics , Hippocampus/physiology , Mice , Mice, Inbred C57BL , Somatosensory Cortex/physiology , Synapses/physiology
7.
PLoS One ; 2(6): e533, 2007 Jun 20.
Article in English | MEDLINE | ID: mdl-17579707

ABSTRACT

To identify the underlying reason for the controversial performance of tetracycline (Tet)-controlled regulated gene expression in mammalian neurons, we investigated each of the three components that comprise the Tet inducible systems, namely tetracyclines as inducers, tetracycline-transactivator (tTA) and reverse tTA (rtTA), and tTA-responsive promoters (P(tets)). We have discovered that stably integrated P(tet) becomes functionally silenced in the majority of neurons when it is inactive during development. P(tet) silencing can be avoided when it is either not integrated in the genome or stably-integrated with basal activity. Moreover, long-term, high transactivator levels in neurons can often overcome integration-induced P(tet) gene silencing, possibly by inducing promoter accessibility.


Subject(s)
Brain/metabolism , Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics , Gene Expression Regulation , Gene Silencing/drug effects , Tetracycline/pharmacology , Trans-Activators/genetics , Animals , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , In Situ Hybridization , Luciferases/genetics , Luciferases/metabolism , Mice , Mice, Transgenic , Polymerase Chain Reaction , Promoter Regions, Genetic/genetics , Trans-Activators/drug effects , Transcriptional Activation/drug effects
8.
Mol Cell Neurosci ; 31(2): 376-86, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16376568

ABSTRACT

The role the cytoskeleton plays in generating and/or maintaining gephyrin-dependent receptor clusters at inhibitory synapses is poorly understood. Here, the effects of actin cytoskeleton disruption were investigated in eGFP-gephyrin-transfected cells and hippocampal neurons. While gephyrin was not associated with microfilaments in transfected cells, it colocalized with G-actin and cytochalasin-D-induced F-actin patches. The linker region between the MoeA and MogA homology domains of gephyrin was required for colocalization with F-actin patches and for the binding of gephyrin to ena/VASP, an actin anti-capping factor that, in vitro, caused gephyrin binding to polymerized actin. In hippocampal neurons, treatment with cytochalasin D resulted in the redistribution of the neuronal ena/VASP homologue Mena into actin patches and, at early stages of development, a reduction in the number of gephyrin clusters. Our data suggest that Mena binding to F-actin allows for gephyrin recruitment to the leading edge of uncapped actin filaments.


Subject(s)
Actins/metabolism , Carrier Proteins/metabolism , Cell Adhesion Molecules/metabolism , Cytoskeleton/metabolism , Membrane Proteins/metabolism , Microfilament Proteins/metabolism , Phosphoproteins/metabolism , Actin Cytoskeleton/metabolism , Actins/genetics , Animals , Antineoplastic Agents/pharmacology , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Carrier Proteins/genetics , Cell Adhesion Molecules/genetics , Cells, Cultured , Cytochalasin D/pharmacology , Cytoskeleton/drug effects , Depsipeptides/pharmacology , Hippocampus/cytology , Humans , Membrane Proteins/genetics , Microfilament Proteins/genetics , Neurons/cytology , Neurons/metabolism , Nucleic Acid Synthesis Inhibitors/pharmacology , Phosphoproteins/genetics , Protein Structure, Tertiary , Rats , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Synapses/metabolism , Synapses/ultrastructure , Thiazoles/pharmacology , Thiazolidines
SELECTION OF CITATIONS
SEARCH DETAIL
...